{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:12:26Z","timestamp":1791317546309,"version":"4.3.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1067\/mhj.2001.109951","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:18:43Z","timestamp":1027556323000},"page":"S49-S57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"special_numbering":"S","title":["Established and emerging cardiovascular risk factors"],"prefix":"10.1067","volume":"141","author":[{"given":"David","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2001.109951_bib1_1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of the European and other Societies on Coronary Prevention","volume":"19","author":"Wood","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.109951_bib1_2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00004872-199816100-00003","volume":"16","year":"1998","journal-title":"J Hypertens"},{"key":"10.1067\/mhj.2001.109951_bib1_3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0021-9150(98)90209-X","volume":"140","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1067\/mhj.2001.109951_bib2","series-title":"Prevention of coronary heart disease. Report of a WHO Expert Committee. WHO Technical Report Series 678","year":"1982"},{"key":"10.1067\/mhj.2001.109951_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/bmj.311.6998.171","article-title":"Fetal origins of coronary heart disease","volume":"311","author":"Barker","year":"1995","journal-title":"BMJ"},{"key":"10.1067\/mhj.2001.109951_bib4","series-title":"Cardiovascular disease risk factors: new areas for research. Report of a WHO Scientific Group. WHO Technical Report Series 841","year":"1994"},{"key":"10.1067\/mhj.2001.109951_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"An updated coronary risk profile: a statement for health professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198408233110804","article-title":"Fibrinogen as a risk factor for stroke and myocardial infarction","volume":"311","author":"Wilhelmsen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109951_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(86)90111-X","article-title":"Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study","volume":"ii","author":"Meade","year":"1986","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib8","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"},{"key":"10.1067\/mhj.2001.109951_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.83.3.836","article-title":"Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart diseases: the Caerphilly and Speewell collaborative heart disease studies","volume":"83","author":"Yarnell","year":"1991","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0038-1642456","article-title":"Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIc and PAI-1 in European offspring: the EARS study","volume":"71","author":"Bara","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.109951_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.CIR.93.3.440","article-title":"Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study","volume":"93","author":"Behague","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib12","series-title":"Atherosclerotic vascular disease, hemostasis, and endothelial function","first-page":"1","article-title":"Fibrinogen and other clotting factors in cardiovascular disease","author":"Meade","year":"1992"},{"key":"10.1067\/mhj.2001.109951_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.ATV.17.8.1539","article-title":"Coagulation factor VII and the risk of coronary heart disease in healthy men","volume":"17","author":"Junker","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2001.109951_bib14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/01.ATV.13.12.1829","article-title":"Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis","volume":"13","author":"Folsom","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1067\/mhj.2001.109951_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","article-title":"Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction","volume":"313","author":"Hamsten","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109951_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction","volume":"ii","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib17","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele specific increase in basal transcription of the PAI-1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1067\/mhj.2001.109951_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0038-1649833","article-title":"The 4G\/5G genetic polymorphism in the promotor of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM","volume":"74","author":"Ye","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.109951_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.84.2.613","article-title":"Blood platelet count and function are related to total and cardiovascular health in apparently healthy men","volume":"84","author":"Thaulow","year":"1991","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.83.1.38","article-title":"Ischaemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study","volume":"83","author":"Elwood","year":"1991","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib21","first-page":"347","article-title":"Genetic markers: genes involved in thrombosis","volume":"4","author":"Wu","year":"1997","journal-title":"J Cardiovasc Res"},{"key":"10.1067\/mhj.2001.109951_bib22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM199604253341703","article-title":"A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis","volume":"334","author":"Weiss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109951_bib23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(97)05399-3","article-title":"Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis","volume":"350","author":"Walter","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1067\/mhj.2001.109951_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(94)90078-7","article-title":"Relations of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study","volume":"106","author":"Alfthan","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1067\/mhj.2001.109951_bib26","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/01.ATV.17.10.1947","article-title":"Homocysteine and risk of cardiovascular disease in Multiple Risk Factor Interventional Trial","volume":"17","author":"Evans","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2001.109951_bib27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1067\/mhj.2001.109951_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/qjmed\/89.8.571","article-title":"The common \u201cthermolabile\u201d variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia","volume":"89","author":"Harmon","year":"1996","journal-title":"Q J Med"},{"key":"10.1067\/mhj.2001.109951_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","article-title":"Relation between folate status, a common mutation in methylene-tetrahydrofolate reductase, and plasma homocysteine concentrations","volume":"93","author":"Jacques","year":"1996","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Pruduction of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.aje.a008963","article-title":"Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial","volume":"144","author":"Kuller","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1067\/mhj.2001.109951_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.109951_bib33","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reacive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"suppl I","key":"10.1067\/mhj.2001.109951_bib34","first-page":"I-99","article-title":"C-reactive protein (CRP) predicts the risk of coronary heart disease (CHD) in healthy middle-aged men: results from the MONICA-Augsburg cohort study, 1984\/85-1992 [abstract]","volume":"96","author":"Koenig","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.ATV.17.6.1121","article-title":"Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project","volume":"17","author":"Tracy","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2001.109951_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.78.3.273","article-title":"Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease","volume":"78","author":"Mendall","year":"1997","journal-title":"Heart"},{"key":"10.1067\/mhj.2001.109951_bib38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"10.1067\/mhj.2001.109951_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib40","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(97)03079-1","article-title":"Chronic infections and coronary heart disease: is there a link?","volume":"350","author":"Danesh","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib41","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0735-1097(96)00055-1","article-title":"Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease","volume":"27","author":"Muhlestein","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109951_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","article-title":"Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction","volume":"96","author":"Gupta","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(97)07201-2","article-title":"Randomised trial of roxithromycin in non Q wave coronary syndromes: ROXIS pilot study","volume":"350","author":"Gurfinkel","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib44","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.ATV.16.10.1250","article-title":"Apolipoprotein E allele and risk of coronary disease a meta-analysis","volume":"16","author":"Wilson","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"suppl K","key":"10.1067\/mhj.2001.109951_bib45","doi-asserted-by":"crossref","first-page":"K13","DOI":"10.1093\/eurheartj\/16.suppl_K.13","article-title":"The angiotensin-I converting enzyme (ACE) gene polymorphism and coronary heart disease","volume":"16","author":"Cambien","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.109951_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.CIR.96.3.741","article-title":"Association of angiotensin-converting enzyme gene I\/D polymorphism with change in left ventricular mass in response to physical training","volume":"96","author":"Montgomery","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.CIR.96.1.56","article-title":"D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting","volume":"96","author":"Amant","year":"1997","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.CIR.97.2.147","article-title":"Plasma activity and insertion\/deletion polymorphism of angiotensin I-converting enzyme is a major risk factor and a marker of risk of coronary stent restenosis","volume":"97","author":"Ribichini","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.109951_bib49","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/0735-1097(95)00090-Q","article-title":"Deletion-allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction","volume":"25","author":"Pinto","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109951_bib50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0735-1097(96)00098-8","article-title":"The DD genotype of the angiotensin converting enzyme gene is associated with increased mortality in idiopathic heart failure","volume":"28","author":"Andersson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.109951_bib51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.ATV.16.3.386","article-title":"The acute rise in plasma fibrinogen concentration with exercise is influenced by the G453A polymorphism of the fibrinogen gene","volume":"16","author":"Montgomery","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1067\/mhj.2001.109951_bib52","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1055\/s-0038-1656123","article-title":"Positive association of the fibrinogen H1\/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction","volume":"77","author":"Gardemann","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1067\/mhj.2001.109951_bib53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.18.2.265","article-title":"455G\/A polymorphism of the fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men","volume":"18","author":"De Maat","year":"1998","journal-title":"Arterioscler Thromb Basc Biol"},{"key":"10.1067\/mhj.2001.109951_bib54","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI118207","article-title":"Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction","volume":"96","author":"Fumeron","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1067\/mhj.2001.109951_bib55","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(97)01029-5","article-title":"Polymorphisms of a-adducin and salt sensitivity in patients with essential hypertension","volume":"349","author":"Cusi","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.109951_bib56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/hrt.75.4.334","article-title":"A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE","volume":"75","author":"Bowker","year":"1996","journal-title":"Heart"},{"key":"10.1067\/mhj.2001.109951_bib57","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/oxfordjournals.eurheartj.a015136","article-title":"A European Society of Cardiology survey of secondary prevention of CHD: principal results. European Action on Secondary Prevention through Intervention to Reduce Events","volume":"18","author":"EUROASPIRE study group","year":"1997","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301011516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301011516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:49:46Z","timestamp":1757566186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870301011516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S0002870301011516"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2001.109951","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Established and emerging cardiovascular risk factors","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mhj.2001.109951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}